Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

EVFM

Evofem Biosciences (QB) (EVFM)

Evofem Biosciences Inc (QB)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:EVFM
FechaHoraFuenteTítuloSímboloCompañía
15/05/202405:50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:EVFMEvofem Biosciences Inc (QB)
15/05/202405:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:EVFMEvofem Biosciences Inc (QB)
14/02/202413:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:EVFMEvofem Biosciences Inc (QB)
25/01/202415:23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:EVFMEvofem Biosciences Inc (QB)
12/01/202416:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EVFMEvofem Biosciences Inc (QB)
29/08/202315:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:EVFMEvofem Biosciences Inc (QB)
18/08/202315:08Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsUSOTC:EVFMEvofem Biosciences Inc (QB)
14/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:EVFMEvofem Biosciences Inc (QB)
14/08/202316:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:EVFMEvofem Biosciences Inc (QB)
03/08/202316:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:EVFMEvofem Biosciences Inc (QB)
16/06/202316:01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:EVFMEvofem Biosciences Inc (QB)
16/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EVFMEvofem Biosciences Inc (QB)
12/05/202315:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:EVFMEvofem Biosciences Inc (QB)
27/04/202316:29Edgar (US Regulatory)Annual Report (10-k)USOTC:EVFMEvofem Biosciences Inc (QB)
12/04/202305:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:EVFMEvofem Biosciences Inc (QB)
31/03/202315:03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:EVFMEvofem Biosciences Inc (QB)
06/03/202313:49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:EVFMEvofem Biosciences Inc (QB)
15/02/202315:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:EVFMEvofem Biosciences Inc (QB)
27/01/202305:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:EVFMEvofem Biosciences Inc (QB)
03/10/202205:49Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:EVFMEvofem Biosciences Inc (QB)
30/09/202215:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:EVFMEvofem Biosciences Inc (QB)
23/09/202216:06Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:EVFMEvofem Biosciences Inc (QB)
 Showing the most relevant articles for your search:USOTC:EVFM

Su Consulta Reciente

Delayed Upgrade Clock